Caroline S Levy
CIK 1820042 · last filed 2026-03-03
Caroline S Levy is a corporate insider who has filed 10 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for CELH, was dated Mar 3, 2026. Across all open-market trades the lifetime net is −$9.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.32M
2
10
-$9.31M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CELH | Director | 45,367 | $29.18 | $1.32M | -$9.31M | 9 | 2026-03-03 |
| Niagen Bioscience, Inc. (CDXC) Delisted | Director | — | $7.87 | — | $0 | 1 | 2021-12-02 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-03 | CELH | Grant (A) | +2,611 | $0 | EDGAR |
| 2025-03-13 | CELH | Mixed | — | -$1.54M | EDGAR |
| 2025-03-04 | CELH | Grant (A) | +4,865 | $0 | EDGAR |
| 2024-03-14 | CELH | Mixed | — | -$1.80M | EDGAR |
| 2024-03-05 | CELH | Grant (A) | +1,576 | $0 | EDGAR |
| 2023-08-14 | CELH | Sell (S) | −30,500 | -$5.24M | EDGAR |
| 2023-05-25 | CELH | Sell (S) | −2,200 | -$295.9K | EDGAR |
| 2023-04-24 | CELH | Grant (A) | +18,700 | $0 | EDGAR |
| 2023-01-05 | CELH | Grant (A) | +1,105 | $0 | EDGAR |
| 2021-12-02 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | — | $0 | EDGAR |